Moderna, Inc. - COMMON STOCK (MRNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
MRNA on Nasdaq
Shares outstanding
384,509,293
Price per share
$29.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
274,563,704
Total reported value
$7,091,157,324
% of total 13F portfolios
0%
Share change
-16,974,668
Value change
-$451,925,440
Number of holders
626
Price from insider filings
$29.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moderna, Inc. - COMMON STOCK (MRNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -36% $679,099,749 -$379,474,374 24,948,558 -36% BAILLIE GIFFORD & CO 31 Mar 2025
FMR LLC 3.2% -38% $317,820,001 -$227,968,658 12,304,297 -42% FMR LLC 30 Sep 2025

As of 30 Sep 2025, 626 institutional investors reported holding 274,563,704 shares of Moderna, Inc. - COMMON STOCK (MRNA). This represents 71% of the company’s total 384,509,293 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Moderna, Inc. - COMMON STOCK (MRNA) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 11% 41,185,295 -1.3% 0.02% $1,063,816,169
BlackRock, Inc. 7.7% 29,527,917 +3.2% 0.01% $762,706,089
BAILLIE GIFFORD & CO 5.7% 21,846,666 -1.1% 0.42% $564,299,382
STATE STREET CORP 4.4% 17,108,595 -0.94% 0.02% $441,915,009
FMR LLC 3.2% 12,304,297 -37% 0.02% $317,820,001
MORGAN STANLEY 2.6% 9,962,232 +23% 0.02% $257,324,501
GEODE CAPITAL MANAGEMENT, LLC 2.4% 9,249,352 +4.2% 0.02% $238,477,440
Invesco Ltd. 2.1% 8,216,163 +16% 0.03% $212,223,494
Theleme Partners LLP 2.1% 8,068,810 +2.5% 13% $208,417,362
TWO SIGMA INVESTMENTS, LP 2% 7,529,981 +8.2% 0.3% $194,499,409
TWO SIGMA ADVISERS, LP 1.8% 6,772,900 -13% 0.35% $174,944,007
D. E. Shaw & Co., Inc. 1.6% 6,146,374 -18% 0.13% $158,760,840
UBS Group AG 1.2% 4,801,547 +22% 0.02% $124,023,958
Flagship Pioneering Inc. 1.2% 4,632,149 0% 41% $119,648,409
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 4,312,432 +42% 0.02% $111,390,108
GOLDMAN SACHS GROUP INC 0.83% 3,179,749 -6.6% 0.01% $82,132,928
BANQUE PICTET & CIE SA 0.81% 3,130,724 -0.07% 0.81% $80,866,601
NORTHERN TRUST CORP 0.76% 2,905,509 -6% 0.01% $75,049,297
FEDERATED HERMES, INC. 0.72% 2,779,001 -3.1% 0.13% $71,781,595
NATIONAL BANK OF CANADA /FI/ 0.7% 2,704,838 +357% 0.08% $69,865,933
Merck & Co., Inc. 0.6% 2,308,190 0% 26% $59,620,548
CITIGROUP INC 0.54% 2,082,040 -15% 0.04% $53,779,093
BARCLAYS PLC 0.52% 2,015,828 -7.8% 0.02% $52,068,838
CITADEL ADVISORS LLC 0.52% 1,987,731 +8.3% 0.04% $51,343,091
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.51% 1,960,968 -35% 0.01% $50,651,803

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 4,626,612 $136,559,426 -$17,808,136 $29.49 58
2025 Q3 274,563,704 $7,091,157,324 -$451,925,440 $25.83 626
2025 Q2 291,423,621 $8,041,462,409 +$359,301,164 $27.59 663
2025 Q1 278,813,548 $7,903,142,271 -$59,165,632 $28.35 678
2024 Q4 276,578,373 $11,499,056,660 +$341,051,932 $41.58 729
2024 Q3 260,519,054 $17,396,828,362 -$359,670,897 $66.83 765
2024 Q2 261,395,055 $31,036,767,708 -$43,788,037 $118.75 939
2024 Q1 262,225,074 $27,942,962,472 +$671,576,108 $106.56 887
2023 Q4 256,350,763 $25,504,353,761 +$907,888,206 $99.45 869
2023 Q3 246,373,071 $25,443,040,671 -$303,969,124 $103.29 872
2023 Q2 246,506,415 $29,955,571,272 -$272,422,709 $121.50 942
2023 Q1 249,344,037 $38,273,515,844 +$239,644,701 $153.58 996
2022 Q4 248,479,248 $44,642,318,628 +$419,105,140 $179.62 1,049
2022 Q3 246,689,392 $29,178,218,716 +$223,399,465 $118.25 882
2022 Q2 244,256,119 $34,891,994,437 -$466,757,538 $142.85 957
2022 Q1 248,043,088 $42,733,575,812 +$209,409,354 $172.26 983
2021 Q4 246,080,857 $62,455,582,704 -$6,658,229 $253.98 1,078
2021 Q3 225,302,088 $86,681,348,769 +$6,751,024,992 $384.86 1,120
2021 Q2 207,880,167 $48,837,794,090 +$5,169,371,723 $234.98 873
2021 Q1 188,072,205 $24,617,994,062 +$2,907,518,589 $130.95 752
2020 Q4 168,732,531 $17,626,423,609 -$527,763,419 $104.47 688
2020 Q3 204,933,447 $14,493,668,331 -$999,957,835 $70.75 535
2020 Q2 219,125,612 $14,064,229,526 +$1,607,162,122 $64.21 477
2020 Q1 195,768,954 $5,863,724,828 +$637,559,905 $29.95 285
2019 Q4 174,185,916 $3,406,689,342 +$267,799,940 $19.56 157
2019 Q3 109,780,342 $1,747,630,941 +$415,283,859 $15.92 131
2019 Q2 84,483,070 $1,235,871,867 +$117,389,510 $14.64 128
2019 Q1 79,523,801 $1,604,234,442 +$101,479,383 $20.35 101
2018 Q4 133,583,585 $2,019,181,000 +$2,019,011,980 $15.27 75